Aurinia Pharmaceuticals Inc (AUPH)

[Ganz]

I’ve posted this numerous times and will again. Most investors won’t really. Get behind AUPH until they show a proven track record for V sales and a solid balance sheet, we may be waiting until Q1 results for a real pop.but FDA approval takes the risk out of owning the stock.